Grant: Operating Grant
University of Toronto
$210,945.00
Evaluating Accountability, Transparency and Governance in Brazil's Pharmaceutical System
EF 2011-12
Résumé
Corruption in the pharmaceutical sector is an increasing problem because it prevents many patients from accessing medicines that they need. When pharmaceutical drugs are of good quality and used properly by the patients, they offer an affordable solution to many health problems. For example, if essential drugs are provided to poor populations at reasonable prices, many of their diseases can be cured or prevented. This is particularly true in Latin America, which has a collection of very poor populations that suffer from a variety of diseases.
Good governance, accountability and transparency (GAT) are critical for the proper functioning of the pharmaceutical system. To study GAT, we will undertake a case study of Brazil. This project aims to identify laws, regulations and policies that are present in Brazil to improve access to essential medicines, to study how they have been implemented and to determine if they have helped promote good governance, accountability and transparency. The results from this study have the potential to lead to better health outcomes, particularly for the poor populations in Brazil, and more generally to contribute to improving access to medicines in other countries in Latin America.
Programme
Operating Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
253445
Name
Kohler Jillian
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Policy & Systems Management Research
Projecttitle
Evaluating Accountability, Transparency and Governance in Brazil's Pharmaceutical System
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$210,945
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Brazil; Global Health; Governance; Health Equity; Pharmaceutical Policy
Abstract
Corruption in the pharmaceutical sector is an increasing problem because it prevents many patients from accessing medicines that they need. When pharmaceutical drugs are of good quality and used properly by the patients, they offer an affordable solution to many health problems. For example, if essential drugs are provided to poor populations at reasonable prices, many of their diseases can be cured or prevented. This is particularly true in Latin America, which has a collection of very poor populations that suffer from a variety of diseases.
Good governance, accountability and transparency (GAT) are critical for the proper functioning of the pharmaceutical system. To study GAT, we will undertake a case study of Brazil. This project aims to identify laws, regulations and policies that are present in Brazil to improve access to essential medicines, to study how they have been implemented and to determine if they have helped promote good governance, accountability and transparency. The results from this study have the potential to lead to better health outcomes, particularly for the poor populations in Brazil, and more generally to contribute to improving access to medicines in other countries in Latin America.
Competitiondate
201203
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kohler, Jillian
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $210,945~ $0~